Compounding access changed after shortages eased: FDA enforcement discretion around GLP-1 shortage compounding narrowed after tirzepatide injection products were removed from shortage status
In the specific in vitro assay measuring synaptogenesis promotion, Dihexa showed activity at picomolar concentrations far lower than concentrations needed for BDNF or other neurotrophic factors to produce comparable effects
Mackrill JJ (2024) Histidine-rich calcium-binding protein: a molecular integrator of cardiac excitation-contraction coupling
[DOI] [PubMed] [Google Scholar] 182.Andronesi O.C., Nicholson K., Jafari-Khouzani K., Bogner W., Wang J., Chan J., Macklin E.A., Levine-Weinberg M., Breen C., Schwarzschild M.A., et al
Makino E, Frhlich LM, Sinnberg T, Kosnopfel C, Sauer B, Garbe C, et al
doi: 10.1093/geront/gnaf062 [DOI] [PMC free article] [PubMed] [Google Scholar] 565